Spotlight Interview with Caitlyn Clauss from Almac Clinical Services

Caitlyn Clauss, Supply Chain Solutions Manager


  1. Why did you decide to do a webinar with us?

Clinical trials have become increasingly complex in design as investigational products have become more sophisticated, leading sponsors to face increased manufacturing costs, tighter timelines, and limited drug supply. With the estimated cost to bring a new product to market on the rise, the ability to make informed and accurate supply chain decisions is critical as supply chain managers face pressure to conserve drug product and reduce overall IMP costs. As innovators of clinical supply chain management for over 30 years, Almac Clinical Services is committed to helping sponsors develop effective, end-to-end supply chain strategies with the support of technology-based forecasting solutions. In this webinar, we look forward to sharing our expertise with attendees who are interested in leveraging forecasting tools to create optimized, efficient, cost-effective and patient-focused clinical supply chains.


  1. What will the audience gain from attending your webinar?

From initial study planning through study close-out and drug reconciliation, effective supply chain management and forecasting is valuable in delivering a successful clinical trial. Clinical supply chain forecasting methods range from manual spreadsheet calculations to sophisticated simulation technology that utilizes predictive modeling. However, the ultimate goal of every forecasting system is to analyze study parameters and enrollment projections in order to predict supply demand throughout the entire clinical development lifecycle. By harnessing a technology-based approach to demand forecasting, sponsors are able to benefit from increased visibility over their supply chain in order to proactively monitor, manage and align production planning and distribution activity to meet patient demand. By attending our webinar, attendees will gain insight into the fundamentals of forecasting and ways forecasting can optimize clinical supply chain strategies.


  1. What discussions do you look forward to having with the attendees?

The norms of the clinical landscape have shifted considerably over the past few years – targeted therapies, dynamic, study designs, and post-COVID logistical constraints to name a few.  As sponsors and their core vendors consider current study strategies, we welcome the dialogue around how supply-chain risk is being managed and the changes to standard process that sponsors have incorporated in response to patient demands.

Register Now –

Leave a Reply

Your email address will not be published. Required fields are marked *